Table 6 |
||
|
Clinical outcomes in the two treatment groups |
||
|
Fish oil group (n = 13) |
MCT/LCT group (n = 10) |
|
|
|
||
|
Ventilated days |
10 ± 4 |
11 ± 4 |
|
(excluding three patients who died in <5 days) |
(11 ± 5) |
(12 ± 4) |
|
ICU stay (days) |
12 ± 4 |
13 ± 4 |
|
(excluding three patients who died in <5 days) |
(14 ± 5) |
(14 ± 4) |
|
Length of hospital stay (days) |
22 ± 7* |
55 ± 16 |
|
(excluding three patients who died in <5 days) |
25 ± 8** |
61 ± 17 |
|
(excluding all eight patients who died) |
28 ± 9*** |
82 ± 19 |
|
five day mortality |
15% (2 out of 13) |
10% (1 out of 10) |
|
28 day mortality |
31% (4 out of 13) |
40% (4 out of 10) |
|
|
||
|
Data are mean ± SEM, apart from mortality values *P = 0.079 vs. MCT/LCT (Student's t-test with equal variances not assumed; P = 0.062 after adjusting for age and glucose supply; P = 0.038 after adjusting for age, glucose supply and SAPS II at entry); **P = 0.078 vs. MCT/LCT (Student's t-test with equal variances not assumed; P = 0.130 after adjusting for age and glucose supply; P = 0.070 after adjusting for age, glucose supply and SAPS II at entry); ***P = 0.044 vs. MCT/LCT (Student's t-test with equal variances not assumed; P = 0.068 after adjusting for age and glucose supply; P = 0.057 after adjusting for age, glucose supply and SAPS II at entry) |
||
|
Barbosa et al. Critical Care 2010 14:R5 doi:10.1186/cc8844 |
||